desmopressin oral
Selected indexed studies
- Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature. (Arab J Urol, 2018) [PMID:30534439]
- Potential clinical applications of current and future oral forms of desmopressin (Review). (Exp Ther Med, 2024) [PMID:38873038]
- Diabetes insipidus. (Presse Med, 2021) [PMID:34718110]
_Worker-drafted node — pending editorial review._
Connections
desmopressin oral is a side effect of
Sources
- Diabetes insipidus. (2021) pubmed
- Management of central diabetes insipidus. (2020) pubmed
- Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature. (2018) pubmed
- Potential clinical applications of current and future oral forms of desmopressin (Review). (2024) pubmed
- Perioperative management of the bleeding patient. (2016) pubmed
- Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics. (2021) pubmed
- New insights on diagnosis and treatment of AVP deficiency. (2024) pubmed
- The therapeutic effect of oral desmopressin lyophilisate formulation in children with central diabetes insipidus. (2023) pubmed
- Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. (2022) pubmed
- Desmopressin and antifibrinolytics. (1990) pubmed